Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Malaria Journal|January 12, 2018
Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell diseasePaul M Luethy, Sean C Murphy, Annette M Seilie, et al.Journal of Clinical Pharmacology|July 17, 2020
Computer Algorithm-Based Hydroxyurea Dosing Facilitates Titration to Maximum Tolerated Dose in Sickle Cell AnemiaMahogany Oldham, Anna Conrey, Corinne Pittman, et al.Medrxiv : the Preprint Server for Health Sciences|January 27, 2025
Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults with SCDMohamed A E Ali, Emily M Limerick, Matthew M Hsieh, et al.British Journal of Haematology|March 1, 2011
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteersSteven J Lemery, Matthew M Hsieh, Aleah Smith, et al.Plos One|November 18, 2015
Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell AnemiaCourtney D Fitzhugh, Matthew M Hsieh, Darlene Allen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2016
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group ReportMargaret Bevans, Areej El-Jawahri, D Kathryn Tierney, et al.Blood|May 2, 2012
Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell diseaseCourtney D Fitzhugh, Hayato Unno, Vincent Hathaway, et al.Experimental Hematology|May 10, 2011
Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixaforNaoya Uchida, Aylin Bonifacino, Allen E Krouse, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2019
Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque ModelNaoya Uchida, Tina Nassehi, Claire M Drysdale, et al.Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell diseaseBelhu Metaferia, Troy Cellmer, Emily B Dunkelberger, et al.Pageof 9